The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Diagnostic Radiopharmaceuticals & Contrast Media Market Research Report 2024
Synopsis
The global Diagnostic Radiopharmaceuticals & Contrast Media market was valued at US$ 9776.9 million in 2023 and is anticipated to reach US$ 12190 million by 2030, witnessing a CAGR of 3.2% during the forecast period 2024-2030.
North American market for Diagnostic Radiopharmaceuticals & Contrast Media is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Diagnostic Radiopharmaceuticals & Contrast Media is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Diagnostic Radiopharmaceuticals & Contrast Media include Amag Pharmaceuticals, Bayer Healthcare, Bracco Imaging, Daiichi Sankyo, GE Healthcare, Guerbet, Lantheus, Mallinckrodt and Medtronic, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Diagnostic Radiopharmaceuticals & Contrast Media, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Diagnostic Radiopharmaceuticals & Contrast Media.
Report Scope
The Diagnostic Radiopharmaceuticals & Contrast Media market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Diagnostic Radiopharmaceuticals & Contrast Media market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Diagnostic Radiopharmaceuticals & Contrast Media manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Amag Pharmaceuticals
Bayer Healthcare
Bracco Imaging
Daiichi Sankyo
GE Healthcare
Guerbet
Lantheus
Mallinckrodt
Medtronic
Nordion
Segment by Type
Radiopharmaceuticals
Contrast Media
Segment by Application
Hospital
Clinic
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Diagnostic Radiopharmaceuticals & Contrast Media manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Diagnostic Radiopharmaceuticals & Contrast Media in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Diagnostic Radiopharmaceuticals & Contrast Media market was valued at US$ 9776.9 million in 2023 and is anticipated to reach US$ 12190 million by 2030, witnessing a CAGR of 3.2% during the forecast period 2024-2030.
North American market for Diagnostic Radiopharmaceuticals & Contrast Media is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Diagnostic Radiopharmaceuticals & Contrast Media is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Diagnostic Radiopharmaceuticals & Contrast Media include Amag Pharmaceuticals, Bayer Healthcare, Bracco Imaging, Daiichi Sankyo, GE Healthcare, Guerbet, Lantheus, Mallinckrodt and Medtronic, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Diagnostic Radiopharmaceuticals & Contrast Media, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Diagnostic Radiopharmaceuticals & Contrast Media.
Report Scope
The Diagnostic Radiopharmaceuticals & Contrast Media market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Diagnostic Radiopharmaceuticals & Contrast Media market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Diagnostic Radiopharmaceuticals & Contrast Media manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Amag Pharmaceuticals
Bayer Healthcare
Bracco Imaging
Daiichi Sankyo
GE Healthcare
Guerbet
Lantheus
Mallinckrodt
Medtronic
Nordion
Segment by Type
Radiopharmaceuticals
Contrast Media
Segment by Application
Hospital
Clinic
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Diagnostic Radiopharmaceuticals & Contrast Media manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Diagnostic Radiopharmaceuticals & Contrast Media in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Diagnostic Radiopharmaceuticals & Contrast Media Market Overview
1.1 Product Overview and Scope of Diagnostic Radiopharmaceuticals & Contrast Media
1.2 Diagnostic Radiopharmaceuticals & Contrast Media Segment by Type
1.2.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Market Value Comparison by Type (2024-2030)
1.2.2 Radiopharmaceuticals
1.2.3 Contrast Media
1.3 Diagnostic Radiopharmaceuticals & Contrast Media Segment by Application
1.3.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Diagnostic Radiopharmaceuticals & Contrast Media Market Size Estimates and Forecasts
1.4.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue 2019-2030
1.4.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Sales 2019-2030
1.4.3 Global Diagnostic Radiopharmaceuticals & Contrast Media Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Diagnostic Radiopharmaceuticals & Contrast Media Market Competition by Manufacturers
2.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Manufacturers (2019-2024)
2.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Diagnostic Radiopharmaceuticals & Contrast Media Average Price by Manufacturers (2019-2024)
2.4 Global Diagnostic Radiopharmaceuticals & Contrast Media Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Diagnostic Radiopharmaceuticals & Contrast Media, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Diagnostic Radiopharmaceuticals & Contrast Media, Product Type & Application
2.7 Diagnostic Radiopharmaceuticals & Contrast Media Market Competitive Situation and Trends
2.7.1 Diagnostic Radiopharmaceuticals & Contrast Media Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Diagnostic Radiopharmaceuticals & Contrast Media Players Market Share by Revenue
2.7.3 Global Diagnostic Radiopharmaceuticals & Contrast Media Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Diagnostic Radiopharmaceuticals & Contrast Media Retrospective Market Scenario by Region
3.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Global Diagnostic Radiopharmaceuticals & Contrast Media Sales by Region: 2019-2030
3.2.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Sales by Region: 2019-2024
3.2.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Sales by Region: 2025-2030
3.3 Global Diagnostic Radiopharmaceuticals & Contrast Media Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Region: 2019-2030
3.3.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Region: 2019-2024
3.3.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Region: 2025-2030
3.4 North America Diagnostic Radiopharmaceuticals & Contrast Media Market Facts & Figures by Country
3.4.1 North America Diagnostic Radiopharmaceuticals & Contrast Media Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Diagnostic Radiopharmaceuticals & Contrast Media Sales by Country (2019-2030)
3.4.3 North America Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Diagnostic Radiopharmaceuticals & Contrast Media Market Facts & Figures by Country
3.5.1 Europe Diagnostic Radiopharmaceuticals & Contrast Media Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Diagnostic Radiopharmaceuticals & Contrast Media Sales by Country (2019-2030)
3.5.3 Europe Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Diagnostic Radiopharmaceuticals & Contrast Media Market Facts & Figures by Country
3.6.1 Asia Pacific Diagnostic Radiopharmaceuticals & Contrast Media Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Diagnostic Radiopharmaceuticals & Contrast Media Sales by Country (2019-2030)
3.6.3 Asia Pacific Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Diagnostic Radiopharmaceuticals & Contrast Media Market Facts & Figures by Country
3.7.1 Latin America Diagnostic Radiopharmaceuticals & Contrast Media Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Diagnostic Radiopharmaceuticals & Contrast Media Sales by Country (2019-2030)
3.7.3 Latin America Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Diagnostic Radiopharmaceuticals & Contrast Media Market Facts & Figures by Country
3.8.1 Middle East and Africa Diagnostic Radiopharmaceuticals & Contrast Media Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Diagnostic Radiopharmaceuticals & Contrast Media Sales by Country (2019-2030)
3.8.3 Middle East and Africa Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Sales by Type (2019-2030)
4.1.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Sales by Type (2019-2024)
4.1.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Sales by Type (2025-2030)
4.1.3 Global Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Type (2019-2030)
4.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Type (2019-2030)
4.2.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Type (2019-2024)
4.2.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Type (2025-2030)
4.2.3 Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Type (2019-2030)
4.3 Global Diagnostic Radiopharmaceuticals & Contrast Media Price by Type (2019-2030)
5 Segment by Application
5.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Sales by Application (2019-2030)
5.1.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Sales by Application (2019-2024)
5.1.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Sales by Application (2025-2030)
5.1.3 Global Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Application (2019-2030)
5.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Application (2019-2030)
5.2.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Application (2019-2024)
5.2.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Application (2025-2030)
5.2.3 Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Application (2019-2030)
5.3 Global Diagnostic Radiopharmaceuticals & Contrast Media Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Amag Pharmaceuticals
6.1.1 Amag Pharmaceuticals Corporation Information
6.1.2 Amag Pharmaceuticals Description and Business Overview
6.1.3 Amag Pharmaceuticals Diagnostic Radiopharmaceuticals & Contrast Media Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Amag Pharmaceuticals Diagnostic Radiopharmaceuticals & Contrast Media Product Portfolio
6.1.5 Amag Pharmaceuticals Recent Developments/Updates
6.2 Bayer Healthcare
6.2.1 Bayer Healthcare Corporation Information
6.2.2 Bayer Healthcare Description and Business Overview
6.2.3 Bayer Healthcare Diagnostic Radiopharmaceuticals & Contrast Media Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Bayer Healthcare Diagnostic Radiopharmaceuticals & Contrast Media Product Portfolio
6.2.5 Bayer Healthcare Recent Developments/Updates
6.3 Bracco Imaging
6.3.1 Bracco Imaging Corporation Information
6.3.2 Bracco Imaging Description and Business Overview
6.3.3 Bracco Imaging Diagnostic Radiopharmaceuticals & Contrast Media Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Bracco Imaging Diagnostic Radiopharmaceuticals & Contrast Media Product Portfolio
6.3.5 Bracco Imaging Recent Developments/Updates
6.4 Daiichi Sankyo
6.4.1 Daiichi Sankyo Corporation Information
6.4.2 Daiichi Sankyo Description and Business Overview
6.4.3 Daiichi Sankyo Diagnostic Radiopharmaceuticals & Contrast Media Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Daiichi Sankyo Diagnostic Radiopharmaceuticals & Contrast Media Product Portfolio
6.4.5 Daiichi Sankyo Recent Developments/Updates
6.5 GE Healthcare
6.5.1 GE Healthcare Corporation Information
6.5.2 GE Healthcare Description and Business Overview
6.5.3 GE Healthcare Diagnostic Radiopharmaceuticals & Contrast Media Sales, Revenue and Gross Margin (2019-2024)
6.5.4 GE Healthcare Diagnostic Radiopharmaceuticals & Contrast Media Product Portfolio
6.5.5 GE Healthcare Recent Developments/Updates
6.6 Guerbet
6.6.1 Guerbet Corporation Information
6.6.2 Guerbet Description and Business Overview
6.6.3 Guerbet Diagnostic Radiopharmaceuticals & Contrast Media Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Guerbet Diagnostic Radiopharmaceuticals & Contrast Media Product Portfolio
6.6.5 Guerbet Recent Developments/Updates
6.7 Lantheus
6.6.1 Lantheus Corporation Information
6.6.2 Lantheus Description and Business Overview
6.6.3 Lantheus Diagnostic Radiopharmaceuticals & Contrast Media Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Lantheus Diagnostic Radiopharmaceuticals & Contrast Media Product Portfolio
6.7.5 Lantheus Recent Developments/Updates
6.8 Mallinckrodt
6.8.1 Mallinckrodt Corporation Information
6.8.2 Mallinckrodt Description and Business Overview
6.8.3 Mallinckrodt Diagnostic Radiopharmaceuticals & Contrast Media Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Mallinckrodt Diagnostic Radiopharmaceuticals & Contrast Media Product Portfolio
6.8.5 Mallinckrodt Recent Developments/Updates
6.9 Medtronic
6.9.1 Medtronic Corporation Information
6.9.2 Medtronic Description and Business Overview
6.9.3 Medtronic Diagnostic Radiopharmaceuticals & Contrast Media Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Medtronic Diagnostic Radiopharmaceuticals & Contrast Media Product Portfolio
6.9.5 Medtronic Recent Developments/Updates
6.10 Nordion
6.10.1 Nordion Corporation Information
6.10.2 Nordion Description and Business Overview
6.10.3 Nordion Diagnostic Radiopharmaceuticals & Contrast Media Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Nordion Diagnostic Radiopharmaceuticals & Contrast Media Product Portfolio
6.10.5 Nordion Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Diagnostic Radiopharmaceuticals & Contrast Media Industry Chain Analysis
7.2 Diagnostic Radiopharmaceuticals & Contrast Media Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Diagnostic Radiopharmaceuticals & Contrast Media Production Mode & Process
7.4 Diagnostic Radiopharmaceuticals & Contrast Media Sales and Marketing
7.4.1 Diagnostic Radiopharmaceuticals & Contrast Media Sales Channels
7.4.2 Diagnostic Radiopharmaceuticals & Contrast Media Distributors
7.5 Diagnostic Radiopharmaceuticals & Contrast Media Customers
8 Diagnostic Radiopharmaceuticals & Contrast Media Market Dynamics
8.1 Diagnostic Radiopharmaceuticals & Contrast Media Industry Trends
8.2 Diagnostic Radiopharmaceuticals & Contrast Media Market Drivers
8.3 Diagnostic Radiopharmaceuticals & Contrast Media Market Challenges
8.4 Diagnostic Radiopharmaceuticals & Contrast Media Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
